By Harietta Eleftherochorinou, vice president of AI Strategy and Operations, IQVIA
In healthcare and life sciences, core principles remain steadfast: scientific rigor, adherence to regulatory standards and an unwavering commitment to patient trust. Yet, with the emergence of agentic AI, the traditional operating model is undergoing a profound shift.
Agentic AI is not simply streamlining tasks, it is reestablishing the fundamentals of operations, already transforming core functions across the life sciences value chain. In drug discovery, AI agents autonomously identify novel targets, generate compounds, run simulations and optimize leads. In clinical development, they design and dynamically adjust trial protocols, and they recommend proactive mitigation plans for delays or compliance issues, reducing white space. In regulatory strategy, agents prepare regulatory-ready documentation and tailor filings to market-specific requirements. In commercialization, agents synthesize market competitive insights, optimize launch sequencing and orchestrate personalized, multichannel engagement journeys across all channels.
As these capabilities scale, the life sciences industry is entering a new phase of transformation—one that challenges legacy software infrastructure, workforce models and economic constructs. For leaders, the question becomes how to drive change strategically and sustainably to realize the value.
What is changing: From process automation to strategic intelligence
With agentic AI, we are shifting from AI-enhanced solutions and process automation to intelligent, adaptive workflows. In this model, processes are leaner, as AI agents orchestrate and scale operations dynamically, while humans contribute oversight, judgment and domain expertise—bringing together the best of both worlds. The fundamentals of operations are being reestablished.
- Blended operating models
Traditional structures built on human specialization and manual workflows are giving way to hybrid models of expert human–agent collaboration. Agentic AI can also function as a layer of orchestration across scientific, regulatory and commercial domains, breaking silos of the past. Life sciences executives will need to establish new roles, accountability mechanisms and ethical guardrails for agent-to-human and agent-to-agent interactions. - Rearchitecting the technology foundation
Agentic AI requires a flexible, adaptive infrastructure—one that legacy systems, often rigid and integration-heavy, cannot support. In a fast-moving market flooded with emerging solutions, the traditional build–buy–license equation grows more complex. CIOs must lead a structural re-architecture of the tech foundation, while establishing an agile framework to evaluate, adopt and scale agentic tools that align with enterprise strategy. - Redefining economic value
Agentic AI accelerates timelines and holds the potential to boost the probability of technical and regulatory success (PTRS), fundamentally reshaping how value is delivered. Time-based service models are misaligned with these dynamics. In their place, outcome-driven and consumption-based models will emerge, requiring new approaches to pricing, delivery and collaboration.
What stays the same: The core still holds
While agentic AI reestablishes fundamentals of operations, foundational principles remain:
- Evidence and safety standards
Regulatory-grade evidence remains essential. AI can reduce manual burden and accelerate evidence generation and synthesis, but expert validation will remain a cornerstone. - Trust and transparency
As AI becomes embedded in core operations, earning and maintaining stakeholder trust—across regulators, clinicians and patients—will require ongoing investment in transparency, auditability and robust oversight. - Ethics and governance
The complexity of ethical oversight increases with AI autonomy. Human involvement will remain critical, even as tasks shift toward agents.
Change management as a catalyst for enterprise transformation
The rise of agentic AI catalyzes operational, cultural and economic transformation. Historically, life sciences organizations have underinvested in change management, due to the industry’s slower pace of change. However, in today’s environment, change management is not ancillary, but rather core to a successful enterprise strategy. As leaders scale AI, several foundational pillars have emerged as critical to an effective change management strategy.
- Enabling workforce readiness and responsible oversight
Workforce readiness begins with assessing current capabilities and identifying gaps in AI fluency, data literacy and digital collaboration. Building readiness requires structured upskilling programs, new learning formats and a cultural shift that empowers employees to engage with AI confidently and effectively. Meanwhile, responsible oversight is essential for managing the risks associated with agentic autonomy. To drive responsible and effective deployment, companies must implement human-in-the-loop oversight, robust validation protocols and new norms for human–agent collaboration. This also requires redesigning KPIs, incentives and workflows around agent-enabled decision cycles. - Institutionalizing change
Successful transformation requires coordinated, enterprise-wide change. AI transformation centers of excellence are emerging as critical enablers, providing governance, driving standardization and accelerating adoption at scale. Yet, responsibility for AI transformation cannot rest with a single team. It must be embedded across the organization. HR leaders should integrate AI into the employee value proposition—through upskilling, career pathways and engagement models—while business leaders must align AI initiatives with strategic priorities and embed accountability at every level. - Agility
Agentic AI requires agility. These systems are dynamic by nature, making transformation inherently iterative. Meanwhile, the market is evolving rapidly, with new AI tools emerging constantly. Fixed roadmaps no longer suffice. Leaders must embrace adaptive approaches: deploy incremental rollouts with feedback loops, establish flexible governance and maintain transparent, ongoing communication sharing adoption and value metrics. As tools evolve, organizations must be ready to pivot—replacing or upgrading AI systems as needed. Training must evolve to on-demand, role-specific enablement that adapts alongside agent capabilities.
A strategy for lasting impact
Agentic AI is a structural advantage for those ready to act. Early adopters are rearchitecting infrastructure, reskilling talent and embedding AI into decision making. Those who lead with change management will scale faster, adapt smarter and build sustainable advantage in the next era of life sciences.
